Over the span of more than 7.5 years, a network of four nuclear cardiology laboratories substantially reduced radiation doses associated with single-photon emission CT myocardial perfusion imaging ...
Accurate identification of coronary artery disease (CAD) and assessment of its functional severity and significance are paramount for optimal patient care. Marcus Chen of the National Institutes of ...
A cardiac hybrid imaging technique that fuses SPECT myocardial perfusion imaging (MPI) with coronary CT angiography (CCTA) scans can help predict major adverse cardiac events in patients suspected of ...
Harmington, CT - Risk stratification of diabetics is possible with radionuclide myocardial perfusion imaging (MPI), a technique that has previously been shown to be effective in non-diabetics, ...
A multicenter international study has demonstrated for the first time that diagnosis of obstructive coronary artery disease can be improved by using deep learning analysis of upright and supine single ...
Introduction: Functional testing by stress myocardial perfusion imaging (MPI) and anatomical imaging by coronary computed tomography angiography (CCTA) are often used interchangeably in the initial ...
Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon emission ...
Please provide your email address to receive an email when new articles are posted on . Coronary CTA is as useful as direct invasive coronary angiography when evaluating stable chest pain. Coronary CT ...
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ:LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI ...
Researchers have developed a method that leverages artificial intelligence to ensure accurate heart scans without added radiation or cost. Coronary artery disease is the leading cause of death ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent ...